Public Consultation on the draft Evidence-based Gabapentinoid Deprescribing Clinical Guideline
23rd July 2026
A team at The University of Sydney has developed a draft Evidence-based Gabapentinoid Deprescribing Clinical Guideline and is seeking feedback through a public consultation (https://redcap.sydney.edu.au/surveys/?s=CXAJMNLEYDMMCMKA) open from 13 July to 13 August 2026.
Four draft documents are available for review (main guideline, summary of recommendations, dissemination and implementation plan, and technical report).
To support broad stakeholder engagement, the project team would appreciate members sharing the consultation with relevant colleagues and networks as well as providing feedback on any or all of these draft document(s).
Please direct any feedback or enquiries relating to the consultation to Danijela Gnjidic (danijela.gnjidic@sydney.edu.au).